top of page

WHY UGANDA MUST TAKE THE LEAD IN AFRICA’S RARE DISEASE RESEARCH AND PRECISION HEALTH

02/09/25, 16:00

About the Author:
Byarugaba Umar is a medical geneticist, founder of Caremax clinic, a pan-Africanist, and national advocate for rare disease research and precision public health in Uganda.

When a Ugandan mother recently appeared in the Daily Monitor pleading for help to treat her children’s rare genetic skin disorder, the story pierced the nation’s conscience. Her two young children were born with Epidermolysis Bullosa (EB)—a devastating condition where the skin blisters and peels at the slightest touch. The estimated cost of treatment abroad was an impossible UGX 10 billion, per child, nearly half of what it takes to equip a district hospital.

But this story is not an isolated tragedy. It is a mirror reflecting a hidden epidemic- an epidemic of undiagnosed, misdiagnosed, and untreated rare genetic diseases silently affecting thousands of Ugandan families.

The Illusion of Rarity

Globally, rare diseases affect about 1 in every 10 people, meaning over 4 million Ugandans could be living with one. Most of these conditions—like cystic fibrosis, sickle cell disease, muscular dystrophy, or Wilson’s disease—are genetic in origin. Yet because we haven’t established a national genomic testing framework, most patients are never correctly diagnosed.
They are told they have “ drug resistant hypertension,” “ severe asthma,” or “mental illness” when, in truth, they carry rare gene mutations that alter their body’s chemistry in unique ways.

This means that rare diseases are not rare in impact. They are common in consequence—they are the unseen roots of chronic illness, unexplained infertility, learning disabilities, and even medication reactions that kill. Every Ugandan family touched by chronic or mysterious illness is a potential rare disease family.

The mystery of “rare diseases”

While majority simply look at rare diseases as the few identified victims of genetic disorders, the notion of RARE DISEASE is much bigger than we can imagine. It’s less about diseases themselves and more about how we diagnose diseases, how we treat disease and the definition of “disease” itself.

Currently, up to 10,000 different rare diseases have been identified with majority attached to specific proteins. Sickle cell for instance is due to a faulty protein, hemoglobin, hemophilia similarly due to a faulty protein factor 8 or 9. And guess what, the human body has over 100,000 distinct functional proteins coded by the 20,000 human genes. This means we have barely scratched how many rare diseases exist, far more beyond the currently documented ones. As you dig deeper, you realize rare disease is not a challenge doctors will solve, it a mathematical- biological dilemma that will require a strategic integration of genomics, artificial intelligence and big data as global health transitions into the next paradigm of medicine.

Uganda's Genetic Sovereignty, a Scientific Goldmine

Africa is the cradle of humanity, and Uganda possesses some of the most genetically diverse populations on the planet. This diversity is not a challenge; it is our greatest scientific asset. The genetic variants that cause disease in Ugandans are often different from those found in European populations.

By relying on foreign genomic data, we are using an incomplete map to navigate our unique genetic landscape. When we establish our own National Genomic Reference Laboratory, we will not just be diagnosing rare diseases; we will be unlocking discoveries about diabetes, heart disease, and cancer that are specific to our people. This knowledge is power—the power to develop better drugs, predict disease risk, and practice true precision medicine. Surprisingly, Uganda is already well equipped with the tools, the experts but waiting for the “perfect moment” to let genomic medicine guide clinical decisions. The truly exorbitant costs involved genomic testing have successfully hindered this adoption but paradoxically, it’s the very nationwide adoption of genomic testing that will drop the costs and make precision health affordable to Ugandans and Africa at large

A Concrete Path Forward: From Advocacy to Action

Uganda does not need more sympathy; we need a strategic plan. We appeal to our Government, our esteemed representatives in the Ministry of Health, and the private sector to join us in building a future where no family is bankrupted by a diagnosis. Where African genes are analyzed with African genomic reference data. Uganda urgently needs:

  1. A National Rare      Disease Policy and Registry: To formally recognize rare      diseases as a public health challenge, document the cases and create a      framework for action guided by local data.

  2. A National      Genomic Medicine Centre: A public-private partnership to      provide affordable, local genetic testing for high impact genes and make      Uganda a hub for genetic research in Africa.

  3. Workforce      Training:     Integrating basic genetic counselling and genomic medicine into the      curriculum of our health professionals, empowering the next generation      professionals to spot and diagnose rare diseases while gradually      integrating precision medicine

The story of that courageous mother and her children is a mirror held up to our nation. It reflects our compassion, but also our systemic gaps. We can channel this moment of collective empathy into a relentless, unified pursuit of scientific sovereignty.

Uganda has the chance to transform this pain into progress. Let us not just follow the global shift to precision medicine; let us lead it. For the millions of Ugandans waiting in the shadows of a mystery, the time for action is now.

bottom of page